Current Oncology Reports

Papers
(The H4-Index of Current Oncology Reports is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer181
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas119
New Developments in VHL-Associated Neuroendocrine Neoplasms118
NRG1 Fusions: The New Kid on the Block90
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review62
Immunotherapy in Biliary Tract Cancers: Where Are We?60
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review56
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan55
The Difficult Airway in Patients with Cancer54
The Microbiome in Advanced Melanoma: Where Are We Now?52
Head and Neck Mucosal Melanoma: Where Are We Now?48
Current Trends and Challenges of Microbiome Research in Prostate Cancer44
AXL Inhibitors: Status of Clinical Development42
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients41
An Overview of Angiogenesis in Bladder Cancer40
Cellular Therapy in NSCLC: Between Myth and Reality40
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review39
Appendiceal Neuroendocrine Neoplasms: an Update for 202339
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours39
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?35
Targeting the PI3K Pathway in Gynecologic Malignancies33
Proton Therapy in The Treatment of Head And Neck Cancers- Review31
CAR-T Therapies in Solid Tumors: Opportunities and Challenges30
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations30
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)30
Geographical Disparities in Colorectal Cancer in Canada: A Review28
Development of Effective Siglec-9 Antibodies Against Cancer28
Current Management of Neuroendocrine Tumour Liver Metastases27
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma27
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question27
0.16415214538574